Role of sphingomyelin synthesis in pulmonary endothelial cell cytoskeletal activation and endotoxin-induced lung injury

American Journal of Respiratory Cell and Molecular Biology

Volumn 47, Issue 1, 2012, Pages 94-103

  Anjum, Fatima ^a   Joshi, Keval ^a   Grinkina, Natalia ^a   Gowda, Satish ^a   Cutaia, Michael ^a   Wadgaonkar, Raj ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Cytoskeletal rearrangement; Endothelial barrier dysfunction; Sphingomyelin synthase

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; PHOSPHATIDYLCHOLINE SPECIFIC PHOSPHOLIPASE C; PHOSPHOLIPASE C; SMALL INTERFERING RNA; SPHINGOMYELIN; SPHINGOMYELIN SYNTHASE 2; SYNTHETASE; TRICYCLODECAN 9 YL XANTHOGENATE; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ACUTE LUNG INJURY; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG EDEMA; PHOSPHOLIPID SYNTHESIS; PNEUMONIA; PULMONARY ENDOTHELIAL CELL;

ACTINS; ANIMALS; BRIDGED COMPOUNDS; CELLS, CULTURED; CYTOSKELETON; ENDOTHELIAL CELLS; HUMANS; LIPOPOLYSACCHARIDES; LUNG; LUNG INJURY; MICE; PULMONARY ARTERY; RNA INTERFERENCE; RNA, SMALL INTERFERING; SPHINGOMYELINS; THIONES; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS); TYPE C PHOSPHOLIPASES;

BACTERIA (MICROORGANISMS); MURINAE; MUS;

EID: 84863792265     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0458OC     Document Type: Article

References (45)

1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-1349. (Pubitemid 30408719)
2. Dudek SM, Garcia JGN. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001;91:1487-1500. (Pubitemid 32900340)
3. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS. Injurious ventilatory strategies increase cytokines and c-Fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997;99:944-952. (Pubitemid 27123631)
4. Parker JC. Inhibitors of myosin light chain kinase and phosphodiesterase reduce ventilator-induced lung injury. J Appl Physiol 2000; 89:2241-2248.
5. Birukov KG, Jacobson JR, Flores AA, Ye SQ, Birukova AA, Verin AD, Garcia JGN. Magnitude-dependent regulation of pulmonary endothelial cell barrier function by cyclic stretch. Am J Physiol Lung Cell Mol Physiol 2003;285:L785-L797. (Pubitemid 37158824)
6. Bannerman DD, Goldblum SE. Endotoxin induces endothelial barrier dysfunction through protein tyrosine phosphorylation. Am J Physiol 1997;273:L217-L226.
7. Bannerman DD, Goldblum SE. Direct effects of endotoxin on the endothelium: barrier function and injury. Lab Invest 1999;79:1181-1199. (Pubitemid 29489444)
8. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM, Garcia JG. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 2004;169:1245-1251. (Pubitemid 38680403)
9. McVerry BJ, Peng X, Hassoun PM, Sammani S, Simon BA, Garcia JG. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am J Respir Crit Care Med 2004;170:987-993. (Pubitemid 39425695)
10. Wadgaonkar R, Patel V, Grinkina N, Romano C, Liu J, Zhao Y, Sammani S, Garcia JG, Natarajan V. Differential regulation of sphingosine kinases 1 and 2 in lung injury. Am J Physiol Lung Cell Mol Physiol 2009;296:L603-L613.
11. Szczepaniak WS, Zhang Y, Hagerty S, Crow MT, Kesari P, Garcia JG, Choi AM, Simon BA, McVerry BJ. Sphingosine 1-phosphate rescues canine LPS-induced acute lung injury and alters systemic inflammatory cytokine production in vivo. Transl Res 2008;152:213-224.
12. Huitema K, Dikkenberg JVD, Brouwers JF, Holthuis JC. Identification of a family of animal sphingomyelin synthases. EMBO J 2004;23:33-44. (Pubitemid 38165745)
13. Li Z, Hailemariam TK, Zhou H, Li Y, Duckworth DC, Peake DA, Zhang Y, Kuo MS, Cao G, Jiang XC. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization. Biochim Biophys Acta 2007; 1771:1186-1194.
14. Ding T, Li Z, Hailemariam TK, Mukherjee S, Maxfield FR, Wu MP, Jiang XC. SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis. J Lipid Res 2008;49:376-385. (Pubitemid 351213622)
15. Li F, Wu N, Su RB, Zheng JQ, Xu B, Lu XQ, Cong B, Li J. Involvement of phosphatidylcholine-selective phospholipase C in activation of mitogen-activated protein kinase pathways in imidazoline receptor antisera-selected protein. J Cell Biochem 2006;98:1615-1628. (Pubitemid 44141864)
16. Meng A, Luberto C, Meier P, Bai A, Yang X, Hannun YA, Zhou D. Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells. Exp Cell Res 2004; 292:385-392. (Pubitemid 38018853)
17. Yang Y, Yin J, Baumgartner W, Samapati R, Solymosi EA, Reppien E, Kuebler WM, Uhlig S. Platelet-activating factor reduces endothelial NO production: role of acid sphingomyelinase. Eur Respir J 2009;36:417-427.
18. Schütze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Krönke M. TNF activates NF kB by phosphatidylcholine specific phospholipase C induced "acidic" sphingomyelin breakdown. Cell 1992;71:765-776.
19. Gowda S, Yeang C, Wadgaonkar S, Anjum F, Grinkina N, Cutaia M, Xian-Chen Jiang R, Wadgaonkar R. Sphingomyelin synthase 2 (SMS2) deficiency attenuates LPS induced lung injury. Am J Physiol Lung Cell Mol Physiol 2011;300:L430-L440.
20. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387:569-572. (Pubitemid 27248754)
21. Legler DF, Micheau O, Doucey MA, Tschopp J, Bron C. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 2003;18:655-664. (Pubitemid 36588582)
22. Triantafilou M, Miyake K, Golenbock T, Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 2002;115:2603-2611. (Pubitemid 34778077)
23. Tafesse FG, Huitema K, Hermansson M, van der Poel S, van den Dikkenberg J, Uphoff A, Somerharju P, Holthuis JC. Both sphingomyelin synthase SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells. J Biol Chem 2007;282:17537-17547. (Pubitemid 47100300)
24. Tafesse FG, Ternes P, Holthuis JC. The multigenic sphingomyelin synthase family. J Biol Chem 2006;281:29421-29425. (Pubitemid 44536948)
25. Li Z, Hailemariam TK, Zhou H, Li Y, Duckworth DC, Peake DA, Zhang Y, Kuo MS, Cao G, Jiang XC. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization. Biochim Biophys Acta 2007;1771:1186-1194.
26. Hailemariam TK, Huan C, Liu J, Li Z, Roman C, Kalbfeisch M, Bui HH, Peake DA, Kuo MS, Cao G, et al. Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation. Arterioscler Thromb Vasc Biol 2008;28:1519-1526.
27. Amtmann E. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C. Drugs Exp Clin Res 1996;22:287-294. (Pubitemid 27060176)
28. Sultana R, Newman SF, Abdul HM, Cai J, Pierce WM, Klein JB, Merchant M, Butterfield DA. Protective effect of D609 against amyloid-β 1-42 induced oxidative modification of neuronal proteins: redox proteomics study. J Neurosci Res 2006;84:409-417. (Pubitemid 44126293)
29. Zhou DH, Lauderback CM, Yu T, Brown SA, Butterfield DA, Thompson JS. D609 inhibits ionizing radiation-induced oxidative damage by acting as a potent antioxidant. J Pharmacol Exp Ther 2001;298:103-109. (Pubitemid 32574515)
30. Luberto C, Hannun YA. SM synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation: does SM synthase account for the putative PC-specific PLC? J Biol Chem 1998;273:14550-14559. (Pubitemid 28319178)
31. Luberto C, Yoo DS, Suidan HS, Bartoli GM, Hannun YA. Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV40-transformed human fibroblasts. J Biol Chem 2000;275:14760-14766. (Pubitemid 30339770)
32. Adibhatla RM, Hatcher JF. Protection by D609 through cell-cycle regulation after stroke. Mol Neurobiol 2010;41:206-217.
33. Monick MM, Carter AB, Gudmundsson G, Mallampalli RK, Powers LS, Hunninghake GW. A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide- stimulated human alveolar macrophages. J Immunol 1999;162:3005-3012. (Pubitemid 29309330)
34. Zhang F, Zhao G, Dong Z. Phosphatidylcholine-specific phospholipase C and D in stimulation of RAW264.7 mouse macrophage-like cells by lipopolysaccharide. Int Immunopharmacol 2001;1:1375-1384. (Pubitemid 32522989)
35. Machleidt T, Kramer B, Adam D, Neumann B, Schutze S, Wiegmann K, Kronke M. Function of the p55 TNF receptor "death domain" mediated by phosphatidylcholine-specific PLC. J Exp Med 1996;184:725-733. (Pubitemid 26324126)
36. Cobb RR, Felts KA, Parry GC, Mackman N. D609, a phosphatidylcholinespecific phospholipase C inhibitor, blocks interleukin-1 beta-induced vascular cell adhesion molecule 1 gene expression in human endothelial cells. Mol Pharmacol 1996;49:998-1004. (Pubitemid 26181427)
37. Weber C, Erl W, Pietsch A, Danesch U, Weber PC. Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 1995;15:622-628.
38. Birukova AA, Smurova K, Birukov KG, Kaibuchi K, Garcia JGN, Verin AD. Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction. Microvasc Res 2004;67:64-77. (Pubitemid 38050225)
39. Garcia JG, Verin AD, Schaphorst KL. Regulation of thrombin-mediated endothelial cell contraction and permeability. Semin Thromb Hemost 1996;22:309-315. (Pubitemid 26414408)
40. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann N Y Acad Sci 2008;1123:134-145. (Pubitemid 351431312)
41. Chiang ET, Camp SM, Dudek SM, Brown ME, Usatyuk PV, Zaborina O, Alverdy JC, Garcia JGN. Protective effects of high-molecular weight polyethylene glycol (PEG) in human lung endothelial cell barrier regulation: role of actin cytoskeletal rearrangement. Microvasc Res 2009;77:174-186.
42. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamburg JR, English D. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by EDG-dependent cytoskeletal rearrangement. J Clin Invest 2001;108:689-701. (Pubitemid 32906197)
43. Liu F, Schaphorst KL, Verin AD, Jacobs K, Birukova A, Day RM, Bogatcheva N, Bottaro DP, Garcia JG. Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3beta. FASEB J 2002;16:950-962. (Pubitemid 34753501)
44. Jacobson JR, Dudek SM, Birukov KG, Ye SQ, Grigoryev DN, Girgis RE, Garcia JGN. Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am J Respir Cell Mol Biol 2004;30:662-670. (Pubitemid 38591217)
45. Cuschieri J, Bulger E, Billgrin J, Garcia I, Maier RV. Acid sphingomyelinase is required for lipid raft TLR4 complex formation. Surg Infect (Larchmt) 2007;8:91-106.